Navigation Links
IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
Date:2/6/2008

CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported data for IDX899, a non-nucleoside reverse transcriptase inhibitor (NNRTI) being developed for the treatment of HIV. In the first dosing cohort of an ongoing phase I/II study, eight HIV-1 infected treatment-naive patients receiving 800 mg of IDX899 once-daily achieved a mean reduction in virus level of 2.01 log(10), or 99 percent, after seven days of treatment. Additionally, two posters detailing the in-vitro resistance and pharmacokinetic profile in man of IDX899 were presented at the 2008 Conference on Retroviruses and Opportunistic Infections (CROI) this week in Boston, MA.

"New once-a-day NNRTIs that offer improved resistance and safety profiles over what is currently available would be a valuable asset to HIV-treating physicians," said Dr. Douglas Richman, Professor of Pathology and Medicine, University of California San Diego, and Director of the UCSD Center for AIDS Research. "The early profile of IDX899 shows promise and warrants continued clinical evaluation as a potential HIV therapy."

Interim Proof of Concept Data in HIV-infected Patients

An ongoing phase I/II clinical trial is evaluating the safety, tolerability and antiviral activity of IDX899. In the first cohort of the study, ten HIV-1-infected treatment-naive patients were randomized 8:2 to receive once-daily 800 mg IDX899 or matching placebo, respectively, for seven days.

Patients receiving once-daily 800 mg of IDX899 achieved a mean and median plasma viral load reduction of 2.01 and 2.11 log(10),
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Multiple Dose Clinical Trial of TorreyPines Therapeutics Tezampanel Demonstrates Compound is Safe and Well-Tolerated
2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
3. TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkins Lymphoma
4. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
5. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
6. Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema
7. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
8. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
9. Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
10. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
11. Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control & Sexual Function in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...   BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... cold chain management app for smart shippers ... Magazine has included BioLife in its annual list of ... Washington state for 2015. Now in ...
(Date:7/2/2015)... 2, 2015 Legal-Bay LLC, The Lawsuit Settlement ... Joseph Goodwin in the Southern District of ... mesh cases against Ethicon for a single trial to ... for the 26 women include claims from the women ... my Johnson & Johnson,s Ethicon subsidiary. The cases against ...
(Date:7/1/2015)... , July 1, 2015 The Coalition ... of state and regional professional rheumatology societies, today ... rheumatologists that explored perceptions of biosimilars and the ... Biosimilars are medicines that are ... They are notably different from generic medications in ...
Breaking Medicine Technology:BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2
... N.J., Sept. 20 Princeton HealthCare System (PHCS) ( www.princetonhcs.org ... October 4, when it hosts a discussion about women,s pelvic ... program begins at 7 p.m. and can be joined by ... "Social media has enormous potential for sharing information ...
... and plant closure, the company still outpaces Advil in ... released today. The study showed that ... the same way they instinctively perceive and judge other ... and these judgments are highly predictive of brand purchase ...
Cached Medicine Technology:First Live Web Chat by New Jersey's Princeton HealthCare System Focuses on Women's Health 2Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges 2
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... and Emerging Healthcare Delivery Coalition met for the late June Web-based session, the ... with new reimbursement schemes and managing high-risk patients through coordinated care. , During ...
(Date:7/2/2015)... Beach, CA (PRWEB) , ... July 02, 2015 ... ... surgical procedures and executing them with care and precision. There is an art ... FAACS, has had the honor of successfully reshaping the facial features and lives ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... (CVR) recently received nearly $4 million through five federal grants to study ... and therapies against the deadly diseases. , The research will be conducted ...
(Date:7/2/2015)... ... 02, 2015 , ... B. E. Smith, the only full-service ... a national chief executive officer recruitment for Indiana Blood Center in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of the Gelatin Capsule manufacturers. The report is a valuable source of guidance ... depicts the global and Chinese market for the Gelatin Capsule industry including capacity, ...
Breaking Medicine News(10 mins):Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
... When it comes to the attractiveness of orthodontic braces, ... The study of the public,s attitude about the attractiveness of ... appliances with no visible metal were considered the most attractive. ... clear wires were a less desirable option, and braces with ...
... WEDNESDAY, July 9 (HealthDay News) -- Being born extremely underweight ... as an adult. , A study published in the July ... were born at extremely low birth weights were more likely ... had been born at normal weights. , And that ...
... Reaches Out to Patients in Need of ... Care ... DaVita,Medical Missions(TM), a non-profit organization founded by DaVita Inc. that,focuses on bringing ... clinic in India in late,June. The new clinic is located in the ...
... U.S. Senate to vote soon on legislation that ... Minnesota, WASHINGTON, July 9 Seniors across ... Medicare Advantage program in,legislation being considered in the ... million from the Medicare Advantage program in,Minnesota alone ...
... the U.S. Senate,prepares to vote on legislation that would ... (AMA) is calling on Senators,to cast a yes vote ... In,June, the House passed the Medicare Improvements for Patients ... bipartisan vote of 355 to 59., "Last week, ...
... matinee, throughout U.S.,to debut film targeting Lazard CEO, ... residents from,controversial assisted living provider Atria Senior Living ... Thursday in a "rolling,matinee" to debut a new ... Films about Atria,s mistreatment of its workers and,elderly ...
Cached Medicine News:Health News:Survey: Most effective dental braces are least attractive 2Health News:Survey: Most effective dental braces are least attractive 3Health News:Do Underweight Newborns Make for Shy Adults? 2Health News:U.S. Non-Profit Brings Life-Saving Dialysis Treatment to India 2Health News:U.S. Non-Profit Brings Life-Saving Dialysis Treatment to India 3Health News:Minnesota Seniors Speak Out Against Medicare Advantage Cuts 2Health News:New Film Exposes Bruce Wasserstein and Lazard-linked Elderly Care Facilities Exploiting Seniors 2
... Articulating Tip Laryngoscopes are the ... Industry. The articulating tip aids ... an improved view of epiglottis. ... Optic styles. We guarantee your ...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: